⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 30, 2024Journal of Clinical and Translational HepatologyOpen Access

Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization

Ya-Chao Tao Yonghong Wang Meng-Lan Wang Hong Tang En‐Qiang Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF. This study aimed to explore the role of hUC-MSCs in the treatment of ALF and the underlying mechanisms.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tao et al. (2024) studied this question.

synapsesocial.com/papers/68e6cbfeb6db64358764a3be https://doi.org/10.14218/jcth.2023.00557

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Research Progress on the Application of Human Umbilical Cord Mesenchymal Stem Cells in Acute Liver Failure2025
2Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute-on-Chronic Liver Failure PatientsOriginal Research · 2012 · 396 citations
3Human umbilical cord mesenchymal stem cells protect against ferroptosis in acute liver failure through the IGF1-hepcidin-FPN1 axis and inhibiting iron loadingOriginal Research · 2023 · 6 citations
4Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transferOriginal Research · 2025 · 13 citations
5Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial2024 · 2 citations